
24065-33-6 5-chlorothiophene-2-carboxylic Acid
CAS:24065-33-6. MF:C5H3ClO2S. MW:162.59. EINECS:000-000-0. MDL No.:MFCD00041426
Add to Inquiry
CAS 20054-45-9 | 2-mercapto-N-methylbenzamide
Name: 2-mercapto-N-methylbenzamideCAS number: 20054-45-9Molecular formula: C8H9NOSMolecular weight: 167.23EINECS number: 633-825-5MDL No.:MFCD00136334
Add to Inquiry
CAS 261953-36-0 | 6-Iodo-1H-indazole
Name: 6-Iodo-1H-indazoleCAS number: 261953-36-0Molecular formula: C7H5IN2Molecular weight: 244.03EINECS number: 607-884-2MDL No.:MFCD04114695
Add to Inquiry
CAS 3027931-27-4 | PBA-Q76-O16B
CAS No.3027931-27-4Molecular Weight: 914.27Formula:C47H86BN2O6S4+
Add to Inquiry
CAS 178876-82-9 | Methyl 6-amino-5-bromopicolinate
Name: METHYL 6-AMINO-5-BROMOPICOLINATECAS number: 178876-82-9Molecular formula: C7H7BrN2O2Molecular weight: 231.05EINECS number:MDL No.:MFCD08062950
Add to Inquiry
294855-91-7
Product name: (S) -5- (2,5-dioxyriridin-1-yl) oxy) -5-oxo-2-palmitamidopentanoid acidCAS number: 294855-91-7Molecular formula: C25H42N2O7Molecular weight: 482.61EINECS number:MDL No.:MFCD32695506
Add to Inquiry
1446013-08-6 Fmoc-His-AiB-OH TFA
Product name: Fmoc His Aib OH TFACAS number: 1446013-08-6Molecular formula: C27H27F3N4O7Molecular weight: 576.53EINECS number: 815-122-7MDL No.:
Add to Inquiry
303-26-4 1-(4-chlorobenzhydryl)piperazine
Product name:1-(4-chlorobenzhydryl)piperazineCAS:303-26-4. MF:C17H19ClN2. MW:286.8. EINECS:206-137-4. MDL No.:MFCD00005965
Add to Inquiry
330786-24-8 Ibrutinib Intermediate
CAS:330786-24-8. MF:C17H13N5O. MW:303.32. EINECS:810-090-0. MDL No.:MFCD15146640
Add to Inquiry
54527-65-0 2-(benzylmethylamino)ethyl Acetoacetate
CAS:54527-65-0. MF:C14H19NO3. MW:249.31. EINECS:259-197-9. MDL No.:MFCD00071539
Add to Inquiry
115-69-5 2-Amino-2-methyl-1,3-propanediol
Product name:CAS:115-69-5. MF:C4H11NO2. MW:105.14. EINECS:204-100-7. MDL No.:MFCD00004678
Add to Inquiry
79832-89-6
CAS:79832-89-6. MF:C17H25Br. MW:309.28. EINECS:616-745-5. MDL No.:MFCD00577359
Add to Inquiry
China Olaparib intermediate Manufacturers Factory Suppliers
With our professionalism in the business of mainstream product intermediate, minor intermediate, alternative intermediate we have continuously achieved exciting results. Adhering to the business philosophy of 'customer first, forge ahead', excellent quality and perfect service are our constant promise.Our current challenge is to do everything we can to facilitate getting our Olaparib intermediate to market, starting and expanding new businesses, and training and hiring new employees. We believe that our efforts will improve the performance of our products, reduce the cost of use, and bring direct benefits to our customers. Our team of experts is committed to delivering efficient, cost-effective solutions that maximize our clients’ return on investment. The company strives to improve product competitiveness and advocates the business philosophy of "excellent quality, considerate service, surpass the present, and strive for perfection". With strong strength and broad mind, the company has gathered many professional elites who are responsible and effective in management. We have established a deep and distinctive brand image, with unique innovation, research and development capabilities, and are committed to providing customers and partners with high brand value-added products, technologies and services. We embrace diversity and inclusivity in our workplace and society. We hope to use safety culture to lead all work of safety production, and use safety culture to create corporate safety shields.WEBSep 15, 2021 · Preparation method of olaparib intermediate. Abstract. The invention discloses a method for preparing an olaparib key intermediate compound as shown in...
WEBMay 10, 2019 · In this study, the ORR of veliparib monotherapy in patients with gBRCA1/2-mutated, platinum-resistant or intermediate-sensitive (disease relapse within 6 to 12...
WEBFeb 11, 2022 · Olaparib (Lynparza) is a potent, highly selective inhibitor of poly (ADP-ribose)polymerase enzymes, approved by the U.S. FDA and EMA for the treatment of...
WEBAug 9, 2017 · Olaparib, rucaparib, and niraparib are three inhibitors of poly (ADP-ribose) polymerase (PARP) enzymes that have been recently approved for the treatment of...
WEBIndication: In combination with abiraterone and prednisone or prednisolone for the treatment of adult patients with deleterious or suspected deleterious germline and/or somatic...
WEBFeb 2, 2022 · Olaparib (Lynparza) is a potent, highly selective inhibitor of poly(ADP-ribose)polymerase enzymes, approved by the U.S. FDA and EMA for the treatment of...
